Market Place
Sourcing Support
Endo Partners Paladin Pharma to Commercialize Wynzora in Canada
15 Nov 2024 //
PR NEWSWIRE
PALADIN Releases Playbook & Resource Repository to Support Advocacy Group
06 Mar 2024 //
PR NEWSWIRE
Endo`s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
22 Jan 2024 //
PR NEWSWIRE
Health Canada accepts Paladin’s NDS for epilepsy-linked seizure therapy
09 Aug 2022 //
PHARMACEUTICAL-TECHNOLOGY
Paladin Labs Launches of Xydalba (dalbavancin for injection) in Canada
18 Jan 2022 //
YAHOO FINANCE
Endo Announces Licensing Agreement for Paladin Labs to Abaloparatide
05 Jan 2021 //
PRNEWSWIRE
Veloxis & Endo Ventures Jointly Announce Agreement for Paladin Labs Envarsus XR
06 Jun 2017 //
PR NEWSWIRE
Endo Considers Sale of Paladin Labs to Knight Therapeutics
05 Nov 2016 //
REUTERS
Meet Pharma’s Newest Movers and Shakers
25 Apr 2015 //
THE WALL STREET JOURNAL
Endo Said to be Jousting with Valeant, Shire to Win Salix
20 Feb 2015 //
FIERCE PHARMA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.